PE/Cyanine7 anti-mouse CD45.1 Antibody
- 产品名称:
- PE/Cyanine7 anti-mouse CD45.1 Antibody
- 产品类别:
- 抗体
- 产品编号:
- 110729
- 产品应用:
- 110729
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- SJL mouse thymocytes and splenocytes
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
The A20 antibody does not react with leukocytes or?mouse cells expressing the CD45.2 alloantigen. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation3, in vitro blocking of B cell responses1,2, immunohistochemical staining of frozen sections: OCT embedded7 and acetone-fixed4-6 (direct immunofluorescence detection with fluorochrome conjugated A20 was used in (5) and (6)).
- Additional Product Notes
- BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
- Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
- Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
- Suzuki K, et al. 2000. Immunity 13:691. (IHC-F)
- Werner N, et al. 2002. Arterioscler. Thromb. Vasc. Biol. 22:1567. (IHC-F)
- Lessner SM, et al. 2002. Am. J. Pathol. 160:2145. (FC, IHC-F)
- Chen CC, et al. 2005. P. Natl. Acad. Sci. USA 102:11408 (IHC-F)
- Pascal V, et al. 2007. J. Immunol. 179:1751. (FC)
- Mende I, et al. 2006. Blood 107:1383. (IHC-F, FC)
- Phan TG, et al. 2007. Nature Immunol. 8:992. (FC)
- Wither DR, et al. 2009. J. Immunol. 183:5079. PubMed
- Pascal V, et al.2007. J. Immunol. 179:1751. PubMed
- Lee SW, et al. 2009. J. Immunol. 182:6753. PubMed
- Takada K, et al. 2009. J. Exp Med. 206:2253. PubMed
- Beamer CA, et al. 2007. Am. J. Respir. Cell. Mol. Biol. 37:729. (FC) PubMed
- Li LX, et al. 2010. J. Immunol. 184:1728. PubMed
- Hosoi A, et al. 2008. Cancer Res. 68:3941. (FC) PubMed
- Kenna TJ, et al. 2008. Blood 111:2091. PubMed
- Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
- Product Citations
-
- Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
- Burghardt S, et al. 2013. J Immunol. 191:5574. PubMed
- Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
- Yu Y, et al. 2022. iScience. 25:105004. PubMed
- Sch?nberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
- Zhou J, et al. 2019. Immunity. 50:403. PubMed
- Puiffe ML, et al. 2020. Front Immunol. 11:600012. PubMed
- Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
- Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
- Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
- Kinder JM, et al. 2020. Cell Reports. 31(12):107784.. PubMed
- Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
- Liu Y, et al. 2021. Haematologica. Online ahead of print. PubMed
- Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
- Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
- Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
- Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
- Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
- Jia W, et al. 2021. Nat Commun. 12:2118. PubMed
- Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
- Geng S, et al. 2021. JCI Insight. 6:. PubMed
- Glaros V, et al. 2021. Immunity. 54:2005. PubMed
- Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
- Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
- Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
- Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
- Mansell E, et al. 2020. Cell Stem Cell. . PubMed
- Ronsard L, et al. 2021. Front Immunol. 12:730471. PubMed
- Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
- Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
- Severance AL, et al. 2022. iScience. 25:104400. PubMed
- Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
- Subedi A, et al. 2021. Cell Stem Cell. :. PubMed
- Lebel M?, et al. 2020. Nat Commun. 3.051388889. PubMed
- Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
- Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
- Reimer D, et al. 2020. Cell Reports. 32(6):108030. PubMed
- Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
- Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
- Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
- Koide S, et al. 2022. iScience. 25:103603. PubMed
- Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
- Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
- Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
- Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
- Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
- Niven J, et al. 2019. Cell Rep. 28:21. PubMed
- Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
- Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
- Wilkinson AC, et al. 2019. Nature. 571:117. PubMed
- Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
- Subramanian S, et al. 2022. Nat Immunol. 23:458. PubMed
- Barrigan L, et al. 2013. Infect Immun . 81:2028. PubMed
- Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
- Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
- Zhu Y et al. 2017. The Journal of Neuroscience. 37(9):2362-2376 . PubMed
- Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
- RRID
- AB_1134170 (BioLegend Cat. No. 110729) AB_1134168 (BioLegend Cat. No. 110730)
- Structure
- Protein tyrosine phosphatase (PTP) family, 180-240 kD
- Distribution
-
All hematopoietic cells except mature erythrocytes and platelets of the CD45.1 strain of mice
- Function
- Phosphatase, T and B cell activation
- Ligand/Receptor
- Galectin-1, CD2, CD3, CD4
- Biology Area
- Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
- Molecular Family
- CD Molecules
- Antigen References
-
1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.
- Gene ID
- 19264 View all products for this Gene ID
- UniProt
- View information about CD45.1 on UniProt.org